PHS

PFM Health Sciences Portfolio holdings

AUM $1.15B
This Quarter Return
+26.96%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.73B
AUM Growth
-$1.54B
Cap. Flow
-$1.95B
Cap. Flow %
-112.34%
Top 10 Hldgs %
41.62%
Holding
92
New
18
Increased
6
Reduced
30
Closed
31

Sector Composition

1 Healthcare 84.24%
2 Technology 3.36%
3 Consumer Discretionary 0.65%
4 Financials 0.12%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VC icon
51
Visteon
VC
$3.36B
$1.76M 0.08%
20,313
-129,271
-86% -$11.2M
COUP
52
DELISTED
Coupa Software Incorporated
COUP
$1.42M 0.07%
9,731
-157,592
-94% -$23M
ELGX
53
DELISTED
Endologix Inc
ELGX
$252K 0.01%
159,285
-94,605
-37% -$150K
AMD icon
54
Advanced Micro Devices
AMD
$256B
-890,079
Closed -$25.8M
BPMC
55
DELISTED
Blueprint Medicines
BPMC
0
DXCM icon
56
DexCom
DXCM
$31.2B
-1,712,968
Closed -$63.9M
EQ icon
57
Equillium
EQ
$65.4M
-1,064,979
Closed -$4.05M
FATE icon
58
Fate Therapeutics
FATE
$115M
-881,002
Closed -$13.7M
GDDY icon
59
GoDaddy
GDDY
$19.7B
-723,756
Closed -$47.8M
GS icon
60
Goldman Sachs
GS
$223B
-47,320
Closed -$9.81M
INSP icon
61
Inspire Medical Systems
INSP
$2.52B
-350,870
Closed -$21.4M
LYV icon
62
Live Nation Entertainment
LYV
$37.6B
-197,341
Closed -$13.1M
MCK icon
63
McKesson
MCK
$86.1B
0
MKSI icon
64
MKS Inc. Common Stock
MKSI
$6.68B
-301,611
Closed -$27.8M
PBYI icon
65
Puma Biotechnology
PBYI
$251M
-3,689,538
Closed -$39.7M
PTCT icon
66
PTC Therapeutics
PTCT
$4.46B
-1,654,225
Closed -$55.9M
QURE icon
67
uniQure
QURE
$961M
-1,158,694
Closed -$45.6M
SAGE
68
DELISTED
Sage Therapeutics
SAGE
-373,828
Closed -$52.4M
SYK icon
69
Stryker
SYK
$149B
-207,887
Closed -$45M
TW icon
70
Tradeweb Markets
TW
$27B
-67,157
Closed -$2.48M
TWLO icon
71
Twilio
TWLO
$15.8B
-534,889
Closed -$58.8M
V icon
72
Visa
V
$681B
-134,188
Closed -$23.1M
VYGR icon
73
Voyager Therapeutics
VYGR
$202M
-1,231,954
Closed -$21.2M
WDC icon
74
Western Digital
WDC
$30B
-1,053,001
Closed -$47.5M
XBI icon
75
SPDR S&P Biotech ETF
XBI
$5.3B
0